Overview

Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy

Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
Biochemical response of primary biliary cholangitis-autoimmune hepatitis overlap syndrome induced by mycophenolate mofetil versus cyclosporin A
Phase:
Phase 4
Details
Lead Sponsor:
West China Hospital
Treatments:
Cyclosporine
Cyclosporins
Mycophenolic Acid